Bio-equivalent test required for special dosage formed drugs.

Mr. Yang Kyu-whan, the head administrator of the KFDA reported in the Parliamentary Inspection of Government administration that cardiac, anti-cancer and anti-convulsant drugs, a relatively narrow range of its safety, and special dosage formed drugs like a sustained releasing tablets or inhalent remedies would be designated as items required for a biological equivalent test after due consultati...